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Abstract
During ischemic stroke, malfunction of excitatory amino acid transporters and
reduced synaptic clearance causes accumulation of Glutamate (Glu) and
excessive stimulation of postsynaptic neurons, which can lead to their degeneration
by excitotoxicity. The balance between cell death-promoting (neurotoxic) and
survival-promoting (neuroprotective) signaling cascades determines the fate of
neurons exposed to the excitotoxic insult. The evolutionary conserved Insulin/IGF
Signaling (IIS) cascade can participate in this balance, as it controls cell stress
resistance in nematodes and mammals. Blocking the IIS cascade allows the
transcription factor FoxO3/DAF-16 to accumulate in the nucleus and activate a
transcriptional program that protects cells from a range of insults. We study the
effect of IIS cascade on neurodegeneration in a C. elegans model of excitotoxicity,
where a mutation in a central Glu transporter (glt-3) in a sensitizing background
causes Glu-Receptor –dependent neuronal necrosis. We expand our studies on
the role of the IIS cascade in determining susceptibility to excitotoxic necrosis by
either blocking IIS at the level of PI3K/AGE-1 or stimulating it by removing the
inhibitory effect of ZFP-1 on the expression of PDK-1. We further show that the
components of the Cytohesin/GRP-1, Arf, and PIP5K/PPK-1 complex, known to
regulate PIP2 production and the IIS cascade, modulate nematode excitotoxicity:
mutations that are expected to reduce the complex’s ability to produce PIP2 and
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inhibit the IIS cascade protect from excitotoxicity, while overstimulation of PIP2
production enhances neurodegeneration. Our observations therefore affirm the
importance of the IIS cascade in determining the susceptibility to necrotic
neurodegeneration in nematode excitotoxicity, and demonstrate the ability of
Cytohesin/GRP-1, Arf, and PIP5K/PPK-1 complex to modulate neuroprotection.
Introduction
Stroke/brain ischemia is the fourth leading cause of death in the US [1]. Current
therapeutic interventions have very limited success, and pharmacological trials
based on previous understanding of the neurodegenerative process ended with
disappointment [2–5]. In brain ischemia, waves of destruction propagate from the
acute center of injury to cause cell death by necrosis and apoptosis, while in the
penumbra (the area surrounding the ischemic core), neurons that are initially
‘‘stunned’’ might later die or recover [6–9]. The molecular mechanisms that lead
to these different fates are not fully understood, but the strongest and largest body
of evidence suggests that synaptic accumulation of Glutamate (Glu) and excessive
postsynaptic stimulation is a central mediator of toxicity [10]. During ischemia,
the clearance of Glu by secondary-active Glu transporters (GluTs) declines [11–
14], causing synaptic Glu accumulation, overstimulation of ionotropic Glu
Receptors (GluRs), and a large influx of Ca2+ that might lead to neurodegen-
eration in a process termed excitotoxicity [4, 15–18]. Surprisingly, accumulating
evidence indicates that GluR activation contributes to both cell death and
neuroprotection [2, 4], but our understanding of both Glu-induced and Glu-
independent mechanisms of neuroprotection remains incomplete. We are
therefore interested in identifying neuroprotective mechanisms that might
regulate the susceptibility of neurons to excitotoxicity.
The evolutionary conserved Insulin/IGF Signaling (IIS) cascade was identified
in C. elegans as controlling both animal longevity and cell stress resistance
[19–21]. This cascade includes the nematode Insulin/IGF-1 receptor DAF-2 [22],
the PI3-kinase AGE-1 [23], the PIP3- dependent kinase PDK-1 [24], and the
protein kinase AKT-1 [25], which controls the phosphorylation of the FoxO3-like
transcription factor DAF-16 [26]. Active IIS cascade sequesters DAF-16 in the
cytoplasm, while reduced IIS activity allows unphosphorylated DAF-16 to
equilibrate to the nucleus, where it controls gene expression [27–29]. Mutations
that block this pathway confer cell resistance to insults like oxidative stress [30],
hypoxia [31], and human-disease-related proteotoxins [32–37]. Parallel studies in
mammals show that although in some cases FoxO induces apoptosis [38], the
IIS pathway confers resistance to non-apoptotic insults [37, 39]. We are
therefore interested in the potential of the IIS cascade to mediate cell stress
resistance in the excitotoxic scenario, and regulate susceptibility to excitotoxic
neurodegeneration.
IIS Regulators Cytohesin and PIP5K Modulate Nematode Excitotoxicity
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Cell stress resistance control by IIS is only one of the many signaling pathways
conserved from nematodes to humans. Conservation of function extends also to
the use of Glu and the molecular building blocks that mediate its function as an
excitatory neurotransmitter in the nervous system [40]. We have recently
established a model of neurodegeneration in the nematode using a knockout
(KO) of the critical GluT gene glt-3 [41] in the sensitizing background nuIs5 [42]
(expressing hyperactive Gas and GFP in command interneurons under the glr-1
promoter). This combination causes extensive neuronal necrosis that is dependent
on Ca2+-permeable GluRs, defining it as nematode excitotoxicity [43]. Neuronal
necrotic corpses appear gradually during development (in correlation with the
maturation of Glu signaling in the worm), and peak at the L3 larval stage before
they are removed by engulfment. We further used our model of excitotoxicity in
C. elegans to identify the IIS cascade as a factor that can modulate the extent of
neurodegeneration in both nematodes and mammalian neuronal cultures [44].
We observed that FoxO3/DAF-16 provides neuroprotection from excitotoxicity in
glt-3;nuIs5 worms: both a mutation in PI3K/AGE-1 that blocks IIS from expelling
FoxO3/DAF-16 from the nucleus, and a drug that translocates FoxO3/DAF-16
into the nucleus reduced the extent of neuronal necrosis in nematode
excitotoxicity.
We now look for upstream regulators of IIS in the modulation of excitotoxicity.
We are especially intrigued by the function of a complex of proteins that include
the Guanine Exchange Factor (GEF) Cytohesin/GRP-1, the small G-protein Arf,
and the PIP2-synthesizing enzyme PIP5K/PPK-1. A number of studies in
mammals and flies link the Cytohesin/Arf/PIP5K complex to insulin signaling-
dependent liver metabolism, membrane transport, and cell growth, demon-
strating its functions in providing PIP2 as a substrate for PI3K/AGE-1 and
therefore as a stimulator of the IIS cascade [45–48]. Indeed, blocking Cytohesin
causes a reduction in Akt activation and accumulation of FoxO in the nucleus
of both mammalian liver cells and fly S2 cells [45, 46]. We find the Cytohesin/
Arf/PIP5K complex to be particularly relevant to our study of excitotoxicity
because its components have also been associated with the Post Synaptic
Density (PSD) that orchestrates intracellular signaling complexes associated
with GluRs. These include a Cytohesin-binding scaffolding protein [49–51]
that also binds the PSD-organizing protein PSD-95 [52] and metabotropic
GluRs [53, 54], and Arf1’s association with the GluR-binding protein PICK1
[55]. A few studies address Cytohesin/Arf/PIP5K complex function in C.
elegans, showing that Cytohesin/GRP-1 and Arf can control asymmetric cell
division [56–58], and that PIP5K/PPK-1 functions in neurons to produce PIP2
and maintain neuronal development and integrity [59]. In the present study we
use both IIS inhibition and stimulation to affirm that suppressing the IIS
cascade in glt-3;nuIs5 animals is neuroprotective in nematode excitotoxicity,
and we establish that the IIS-regulating Cytohesin/Arf/PIP5K complex
modulates this neuroprotective effect.
IIS Regulators Cytohesin and PIP5K Modulate Nematode Excitotoxicity
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Materials and Methods
Strains
C. elegans strains were generate and maintained using standard methods. Strains
used in this study include: Nematode Excitotoxicity [43]: ZB1102: Dglt-3 (bz34)
IV; nuIs5 [Pglr-1::gfp-1;Pglr-1::Gas(Q227L) V; lin 15(+)]; zfp-1 KO [60, 61]: RB774:
Dzfp-1 (ok554) III; grp-1 KO [57, 62]: otIs114 Is [Plim-6::gfp; rol-6(d)] I; otIs220 Is
[Pgcy-5::mCherry; rol-6(d)] IV; grp-1 (tm1956) III (we preserved only the grp-1
mutation during the cross with the excitotoxicity strain); arf-1.2 KO [57, 63]:
VC567: Darf-1.2 (ok796) III; ppk-1 Over Expression [59]: EG3361 (lin-15(n765ts)
X oxIs12 [Punc-47::GFP, lin-15+] X, gqIs25 [Prab-3::ppk-1, lin-15(+)] I. (oxIs12 [Punc-47::
GFP, lin-15+] X was eliminated during the cross with our excitotoxicity strain,
while gqIs25 was preserved). ced-4 [64]: MT2551 ced-4(n1162) dpy-17(e164)III.
Some strains were obtained from The Caenorhabditis Genetics Center (CGC, the
University of Minnesota) and the Japanese National Bioresource Project (NBRP,
Tokyo Women’s Medical University School of Medicine). For genotyping,
deletions were followed by PCR, and nuIs5 was followed by the presence of
Pglr-1::GFP. ced-4 was followed initially by the linked dpy phenotype and then
confirmed by sequencing the n1162 allele. To identify animals carrying the
Prab-3::PPK-1 over expressing construct we performed a PCR amplification of a
fragment that detects this fusion construct, using a 59 primer from the rab-3
promoter region and a 39 primer from the ppk-1 genomic sequence. These primers
give a ,400 bp product observed only in gqIs25[Prab-3::PPK-1] animals.
Neurodegeneration quantification
Levels of excitotoxic neurodegeneration were quantified as described by Mano &
Driscoll [43] and in line with standard methods used in studies of other forms of
necrotic neurodegeneration in C. elegans [65, 66]. All neurodegeneration studies
were performed on strains that contain the excitotoxicity-producing combination
of glt-3;nuIs5 (without or with additional mutations). Animals were mounted
with an agar chunk on a cover slip and observed using an inverted DIC
microscope (without anesthesia). The animals on the chunk were screened,
individual animals were classified for their developmental stage, and the number
of degenerating neurons for each animal was recorded. Necrotic neurodegenera-
tion is seen as swollen neurons that look like vacuolated structures (occasionally
verified to correspond to nuIs5/Pglr-1::gfp-expressing cells). Similarly to the
stochastic nature of neuronal necrosis seen with other triggers of necrotic
neurodegeneration in C. elegans (and unlike the more constant developmental
apoptotic cell death), the number of degenerating neurons in the control group is
not stereotypically repeated in exact values (an effect that is further compounded
by the fact that not all of the ,30 glr-1 -expressing ‘‘at-risk’’ neurons ultimately
die by adulthood). Instead, cell death shows a very typical dynamics, as it peaks at
L3 with the maturation of Glu signaling in the worm, and then goes down as cell
corpses are engulfed and removed. The level of neurodegeneration in our
IIS Regulators Cytohesin and PIP5K Modulate Nematode Excitotoxicity
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excitotoxicity model can vary in response to growth conditions, and keeping the
strain running by repeated re-chunking over very long periods can suppress its
levels. Therefore, special care was given to the use of recently isolated or
outcrossed strains, the use of freshly grown (non-stressed) animals in multiple
sessions, and in each session, comparison of test strains to control animals
exposed to identical growth conditions (thus controlling for variations between
experiments, similarly to standard practice in nematode lifespan experiments).
Each bar in figures 1–7 corresponds to at least 30 animals, with over 90 animals
usually scored at L3. As per standards in the nematode necrotic neurodegenera-
tion field, error bars represent SE. Statistical significance of difference between
strains is measured using z score, and is indicated on the graph whenever the
difference is significant. Whenever possible, the basic excitotoxicity strain (glt-
3;nuIs5) used as reference in each experiment was re-isolated from the new cross,
to enhance the similarity with the new strain being tested. Critical new strains
were obtained in two independent crosses and neurodegeneration was scored to
verify the effect in independent strains.
LY294002 treatment
LY294002 (LC Laboratories) drug was dissolved in 100% ethanol to produce a
stock solution of 25 mM. 20 microliter of ethanol without (control) or with
LY294002 were added to 12 well plates with MYOB agar+OP50 bacteria [67] to
produce final concentration of 0.2 mM. After ethanol was absorbed, the worms
were added to these culture plates. After 3 days, the level of neurodegeneration in
head neurons was determined. Worms were kept on fresh drug/control by
chunking them to fresh plates with the appropriate condition (ethanol only or
ethanol+LY294002) and were used for additional sessions of neurodegeneration
scoring. Since ethanol has an inhibitory effect of the basic level of excitability in C.
elegans [68], extra caution was taken to verify the validity of the LY294002 effect
under these conditions. These sets of experiments were run several times, with
large number of animals counted in each one. Figure 1 shows one of these
experiments, with the other ones giving very similar results and an identical trend.
Results
A widely used method of chemical inhibition of the IIS pathway
confers neuroprotection from excitotoxic neurodegeneration in C.
elegans
A number of studies in mammalian cells suggest that blocking the IIS cascade and
AKT activation enhances neuronal apoptosis in excitotoxicity [4, 69–73], while
our previous studies in both nematodes and mouse neuronal cultures suggest that
blocking the IIS cascade reduces excitotoxic necrosis [44]. Most of the
mammalian studies attributing a neuroprotective/anti-apoptotic effect to Akt
stimulation used the PI3K inhibitor LY294002 to inhibit IIS and Akt activation, a
IIS Regulators Cytohesin and PIP5K Modulate Nematode Excitotoxicity
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drug that also shows IIS-blocking effects in C. elegans [74]. To address this
possible controversy and further verify that blocking the IIS pathway in
nematodes results in reduced excitotoxic necrosis we monitored the effect of the
LY294002 on nematode excitotoxicity in glt-3(bz34);nuIs5 animals (Figure 1).
Exposing glt-3;nuIs5 animals to the ethanol used to dissolve this drug (without
applying the drug itself) causes a moderate reduction in the number of necrotic
corpses in head neurons compared to non-treated animals (in line with the
reported effects of ethanol exposure on neuronal excitability in nematodes [68]).
However, the overall pattern of necrosis during development in these sham-
treated animals remains similar to that of non-treated glt-3;nuIs5 animals.
Importantly, the application of LY294002 caused a significant reduction in
excitotoxic necrosis compared to sham treated animals, reducing neurodegen-
eration from an average of 3 degenerating head neurons per animal without the
drug to 2 head neurons per animal in the presence of LY294002. These
observations reaffirm that a variety of treatments that reduce the activity of the IIS
cascade activity are neuroprotective in nematode excitotoxicity.
Genetic stimulation of the IIS cascade by zfp-1 mutation increases
susceptibility to nematode excitotoxicity
A particularly strong approach in genetic analysis of signaling cascades is to
demonstrate that over-activation of the cascade leads to an opposite phenotype
than its inhibition. To solidify our understanding of the role of the IIS cascade in
nematode excitotoxicity we therefore studied the effect of its over-activity. The
transcription regulator and AF10 homolog ZFP-1 [61, 75, 76] provides a
particularly interesting opportunity, since it exerts strong regulation over the IIS
Figure 1. LY294002, an inhibitor of PI3K/AGE-1, confers neuroprotection in nematode excitotoxicity.
Sham (ethanol only) treated or LY294002 (ethanol + drug) treated animals were scored for neuronal necrosis
throughout development. Neurodegeneration scoring is described in Materials & Methods. In all histograms,
error bar represent SE. ***: p,0.01.
doi:10.1371/journal.pone.0113060.g001
IIS Regulators Cytohesin and PIP5K Modulate Nematode Excitotoxicity
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cascade. Transcription of the zfp-1 gene is moderately stimulated by FoxO3/DAF-
16 [77, 78]. More importantly for our analysis, ZFP-1 itself is a strong inhibitor of
the IIS cascade: ZFP-1 acts (together with DOT-1) to reduce histone modification
at specific genes and prevent their transcription during stress response [75]. A
prime target of ZFP-1-mediated transcriptional suppression is the gene encoding
the IIS protein PDK-1 (which normally functions to activate AKT in response to
PI3K/AGE-1 stimulation). Therefore, under stress conditions ZFP-1 normally
inhibits PDK-1 expression, leading to increased DAF-16 –mediated stress
resistance. In zfp-1 mutant animals PDK-1 expression goes uninhibited, the IIS
cascade is overactive, and DAF-16-mediated stress resistance is reduced [78]. We
therefore tested the effect of zfp-1 mutation on the susceptibility to excitotoxic
stress. We find that the zfp-1(ok554) mutation indeed causes increased
susceptibility to excitotoxicity, increasing the average number of necrotic neurons
in the L3 stage from 4 to 6 (Figure 2). We therefore affirm that active IIS increases
susceptibility to neurodegeneration while treatments that activate FoxO3/DAF-16
protects from neuronal necrosis in nematode excitotoxicity.
Mutations in Cytohesin/GRP-1 and ARF-1.2, expected to reduce IIS
signaling, confer neuroprotection from excitotoxicity
We next investigated the role of the Cytohesin/GRP-1, Arf, and PIP5K/PPK-1
complex, known to regulate PIP2 production and the IIS cascade, in nematode
excitotoxicity. We used genetic analysis, combining the excitotoxicity genetic
background (glt-3;nuIs5) with mutations that affect this complex. This approach
is usually more productive in C. elegans than pharmacological intervention (which
Figure 2. KO of zfp-1, an inhibitor of PDK-1 transcription, exacerbates nematode excitotoxicity.
**: p,0.05; ***: p,0.01.
doi:10.1371/journal.pone.0113060.g002
IIS Regulators Cytohesin and PIP5K Modulate Nematode Excitotoxicity
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many time is ineffective in the worm) or RNAi (which many times is ineffective in
nematode neurons), though it has its drawbacks. For example, there are a few Arf
homologs in the worm, but only some can be studied by genetic elimination, since
their KO strain is lethal (as is ppk-1 KO). However, we managed to study the KO
of two key components [57, 58, 63]: the GEF Cytohesin/GRP-1 and the small G-
protein ARF-1.2. Since both Cytohesin/GRP-1 and Arf stimulate the activity of the
PIP-2 synthesizing enzyme PIP5K/PPK-1, their KO is expected to reduce PIP5K/
PPK-1 activity, reduce the supply of PIP2 to the IIS cascade and inhibit its activity,
leading to an increase in cell stress resistance. Indeed, in both cases, KO of either
grp-1 (using the tm1956 allele) (Figure 3) or arf-1.2 (using the ok796 allele)
(Figure 4) suppressed neurodegeneration in nematode excitotoxicity.
Modulation of excitotoxic neurodegeneration by GRP-1 is exerted
through the IIS pathway
To verify that the ability of GRP-1 elimination to reduce excitotoxic
neurodegeneration is mediated through the IIS cascade we blocked the IIS cascade
in glt-3;nuIs5 animals using LY294002, and compared animals that have WT grp-1
to animals carrying a grp-1 KO. Neurodegeneration levels in grp-1;glt-3;nuIs5 animals
exposed to LY294002 was very similar to that of glt-3;nuIs5 animals exposed to
LY294002 (Figure 5). These observations suggest that GRP-1 mediates its action on
Figure 3. KO of grp-1, a GEF that stimulates Arf and PIP5K/PPK-1 to increase production of PIP2 substrate for the IIS cascade, provides
neuroprotection. Left: a histogram showing a decrease in neurodegeneration upon KO of grp-1 (a second independent cross gave very similar distribution,
not shown) **: p,0.05; ***: p,0.01. Right: Nomarski/DIC images of neurodegeneration in head neurons. Anterior left, dorsal top, the nerve ring area is
shown (located between the two bulbs of the pharynx), red arrows indicate degenerating neurons. A typical level of neurodegeneration in our excitotoxicity
strain was depicted previously [43]. We note that the extent of neurodegeneration varies among individual animals of the same genotype. Here, the upper
image depicts an individual L3 animal from our excitotoxicity strain with an unusually high level of neurodegeneration. The extensive neurodegeneration
seen in such untypical animals is evened out in the large number of animals used for each bar in our histograms (usually .90 animals in the most
informative stages), bringing average neurodegeneration levels in our excitotoxicity strain (glt-3;nuIs5) to ,4.5 dying head neurons/L3 animal. The bottom
image depicts a typical grp-1;glt-3;nuIs5 L3 animal, a strain that typically shows 2–3 dying head neurons/L3 animal.
doi:10.1371/journal.pone.0113060.g003
IIS Regulators Cytohesin and PIP5K Modulate Nematode Excitotoxicity
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excitotoxic neurodegeneration through the IIS cascade, and inhibiting the cascade
with both a grp-1 mutation and LY294002 has no additional neuroprotective effect.
Over expression of the PIP5K/PPK-1, known to cause excessive
production of PIP2, exacerbates excitotoxic neurodegeneration
To circumvent the challenge of the lethality of ppk-1 KO mutant and to induce a
hyperactivation of the Cytohesin/GRP-1 – PIP5K/PPK-1 complex (and the IIS
Figure 5. Epistasis analysis suggests that grp-1 works in the same pathway as age-1. grp-1 was
inactivated using a KO strain. age-1 was inhibited using the drug LY294002. If these two factors worked in
separate pathways, their ability to suppress neurodegeneration would be (at least partially) additive, a concept
not supported by our observations. The levels of neurodegeneration seen in our original excitotoxicity strain
(under ethanol conditions needed to be used in this experiment) is equally different from the reduced
neurodegeneration seen with inhibition of grp-1, age-1, or both (***: p,0.01).
doi:10.1371/journal.pone.0113060.g005
Figure 4. KO of arf-1.2 provides neuroprotection. **: p,0.05; ***: p,0.01.
doi:10.1371/journal.pone.0113060.g004
IIS Regulators Cytohesin and PIP5K Modulate Nematode Excitotoxicity
PLOS ONE | DOI:10.1371/journal.pone.0113060 November 25, 2014 9 / 17
cascade) we used a strain that exhibits over-expression and excessive activity of
PPK-1. Weinkove et al. found that over-expressing PPK-1 from the powerful pan-
neuronal rab-3 promoter causes excessive production of PIP2, and that mature
neurons are especially susceptible to PPK-1 overexpression [59]. If PPK-1 supplies
the PIP2 substrate for the IIS cascade, then overexpression of PPK-1 should
overstimulate the IIS cascade and cause excessive neurodegeneration. Indeed,
when we introduced the Prab-3::PPK-1 construct to glt-3;nuIs5 animals we saw an
increase in the level of necrotic neurodegeneration (Figure 6). The necrotic effect
of PPK-1 hyperactivation is seen a bit later in development than our usual peak at
L3, appearing instead when the Prab-3:PPK-1 construct produces its full effect [59].
Together with the data on GRP-1 and ARF-1.2, these observations suggest that the
IIS-stimulating complex of Cytohesin/GRP-1, Arf, and PIP5K/PPK-1 serves to
increase susceptibility to excitotoxicity in the nematode.
Nematode excitotoxicity is not affected by a mutation in ced-4
To increase the validity of our conclusion that the Cytohesin/GRP-1, Arf, and
PIP5K/PPK-1 complex regulates the IIS cascade to determine the level of
susceptibility to excitotoxicity, we also tested other possible explanations for the
neuroprotective effect of grp-1 mutation. One alternative explanation is that the
IIS cascade directly regulates the level of expression of GluRs. Our initial
observations using a synaptically localized GLR-1 or behavioral assays do not
provide support for a strikingly large change in GLR-1 expression level, though
these studied are not yet conclusive (data not shown).
Another alternative explanation for the effect of grp-1 on the level of excitotoxic
neurodegeneration is based on the involvement of grp-1 in apoptosis, as seen in
some post-embryonic lineages in the nematode [58]. If apoptosis mediates or
Figure 6. Over Expression of PPK-1, known to lead to over-production of PIP2, exacerbates necrotic
neurodegeneration. **: p,0.05; ***: p,0.01.
doi:10.1371/journal.pone.0113060.g006
IIS Regulators Cytohesin and PIP5K Modulate Nematode Excitotoxicity
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participates in some of the cell death we see in excitotoxic neurodegeneration in
the nematode, a mutation in an apoptosis regulator such as grp-1 could reduce the
extent of cell death. To test the possible involvement of apoptosis as a mediator of
neurodegeneration in our excitotoxicity model we blocked apoptosis using the
ced-4(n1162) mutation [64]. However, similarly to the lack of involvement of
apoptosis in mec-4(d) –induced necrosis [79], the mutation in ced-4 did not affect
the level of excitotoxic neurodegeneration (Figure 7). We therefore conclude that
canonical apoptosis does not play a significant role in the condition that we study,
and therefore cannot explain the ability of Cytohesin/GRP-1 mutation to inhibit
neurodegeneration in nematode excitotoxicity.
Discussion
Activation of the IIS cascade increases susceptibility to nematode
excitotoxicity
The role of the IIS cascade in excitotoxic neurodegeneration seems to be
controversial. A large number of mammalian studies conclude that AKT
activation is neuroprotective, while FoxO3 activation increases apoptotic
neurodegeneration in a variety of conditions including excitotoxicity [4, 69–73].
In contrast, other studies in nematodes and mammals point to a strong
neuroprotective function for IIS cascade inhibition and DAF-16/FoxO3 activa-
tion. Our data on nematode excitotoxicity (and previously also in mammalian
primary cultures [44]) support the neuroprotective view for DAF-16/FoxO3
activation. We now reaffirm our previous observation by using LY294002, the
same drug that was used in the mammalian studies, showing that it causes
neuroprotection (Figure 1). We also hyperactivated the IIS cascade using the zfp-1
Figure 7. Blocking canonical apoptosis using a ced-4 mutation does not suppress cell death in
nematode excitotoxicity.
doi:10.1371/journal.pone.0113060.g007
IIS Regulators Cytohesin and PIP5K Modulate Nematode Excitotoxicity
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mutation and observed excessive necrosis (Figure 2). We are therefore convinced
that an active IIS cascade increases susceptibility to excitotoxic necrosis in C.
elegans, and its inhibition leads to neuroprotection. We do not have a full
explanation to the difference in opinions in the field, other than difference in
experimental setup and the characterization of cell death. Indeed, one clear
difference between our study and previous ones is that we focus very specifically
on necrotic cell death in excitotoxicity, while many other studies might involve
several death mechanisms or focus on apoptotic cell death. The condition that we
study does not seem to involved apoptosis (Figure 7). The ability of FoxO
activation to lead to diverse consequences, depending in the exact combination of
cellular factors, is well documented [38, 80]. We therefore suggest the simplified
scenario of nematode excitotoxicity, where apoptosis is not involved, allows us to
clearly dissect a neuroprotective effect for FoxO/DAF-16, an effect that
participates also in (at least some of-) the more complex scenarios that take place
in mammalian excitotoxicity (as seen in our previous study [44]). In the future,
this might help us illuminate conserved neuroprotection-specific processes in
excitotoxicity downstream of FoxO/DAF-16.
The IIS-stimulating complex of GRP-1 & PPK-1 serves to regulate
excitotoxicity
Our data puts the spotlight on the IIS-regulating Cytohesin/GRP-1, Arf, and
PIP5K/PPK-1 complex and its role in regulating susceptibility to excitotoxicity in
C. elegans. Using epistasis we demonstrate that grp-1 works in the same pathway
as age-1 to regulate neurodegeneration levels. We further show that this effect is
unlikely to involve grp-1’s regulation of apoptosis (seen in some neuronal
lineages), as apoptosis seems not to be involved in nematode excitotoxicity. It is
possible that other IIS cascade-regulated processes might also be influenced by
this complex. However, as the focus of our research is excitotoxicity, our data does
not address those other functions of the IIS cascade. Together with our previous
data on the nuclear translocation of DAF-16 as a means to induce neuroprotec-
tion, our studies are therefore in line with a model where the Cytohesin/GRP-1,
Arf, and PIP5K/PPK-1 complex controls the transcriptional output of the IIS
cascade to regulate susceptibility to excitotoxicity (Figure 8).
The GRP-1 & PPK-1 might serve as a link that allows GluR to
control neuroprotection and susceptibility to excitotoxicity
Our initial interest in the Cytohesin/GRP-1, Arf, and PIP5K/PPK-1 complex was
based on the studies that indicate its physical association with the PSD and with
GluRs. Currently the subcellular localization of this complex is unknown (other
than the observation by Weinkove et al. [59] that PPK-1 is expressed throughout
the cell membrane of all neurons, and could therefore overlap with expression of
GluRs in post-synaptic areas of the neurites). It also remains to be seen if GluRs
provide any input to IIS signaling via the Cytohesin/GRP-1, Arf, and PIP5K/PPK-
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1 complex. It should be noted that ample evidence exists in mammals for a
functional interaction between GluRs and insulin signaling [81–84]. Some of these
studies describe a rapid effect of insulin receptors on GluR distribution [85–88].
Interestingly, a seminal study shows that a phosphatase that degrades PIP3 is
associated with the PSD and serves to suppress excitotoxic neurodegeneration
[89], a scenario that is in line with our model. For the time being we do not know
if some of the neuroprotective or neurotoxic effects of Glu are mediated by GluR-
IIS cross talk that regulates neuroprotection by FoxO/DAF-16. Therefore it is not
clear if the level of IIS signaling is a ‘‘pre-existing condition’’ that determine
susceptibility to neurodegeneration, or if it can be actively modified by Glu
signaling, providing an important venue for Glu to control both neurodegen-
eration and cell survival.
Acknowledgments
We thank Drs. Monica Driscoll, Christine Li, Alla Grishok, and Gian Garriga, and
all members of the Mano & Li labs for their advice and support. We thank Drs.
Gian Garriga, Chris Rongo, David Weinkove, and Oliver Hobert for reagents, Dr.
S. Mitani (Tokyo Women’s Medical University School of Medicine), the C.
elegans Gene Knockout Consortium, and the C. elegans Genetic Center for
providing deletion alleles.
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